年轻成人亚临床动脉粥样硬化的初级预防:JACC综述
综述指出动脉粥样硬化过程早年即启动,年轻成人即使低密度脂蛋白胆固醇在正常范围内,暴露于风险因素仍增加亚临床动脉粥样硬化及远期心血管事件风险。目前无症状年轻人群(<40岁)的最佳风险因素控制目标尚不明确,PRECAD随机对照试验正在评估对20-39岁健康年轻人积极控制风险因素的获益。
要点
- 年轻成人暴露于低密度脂蛋白胆固醇等风险因素增加亚临床动脉粥样硬化
- 无症状年轻人群(<40岁)最佳风险因素控制目标未知
- PRECAD试验评估20-39岁健康年轻人积极控制风险因素的获益
核心结论
- 年轻成人即使低密度脂蛋白胆固醇在正常范围内,暴露于风险因素仍增加亚临床动脉粥样硬化及远期心血管事件风险。
- 无症状年轻人群(<40岁)的最佳心血管风险因素控制目标尚不明确。
研究设计与样本
- 综述类文章,汇总年轻成人亚临床动脉粥样硬化初级预防的证据。
- 提及PRECAD随机对照试验,针对20-39岁无已知心血管疾病的健康年轻人。
主要发现
- 年轻成人暴露于低密度脂蛋白胆固醇及其他心血管风险因素,即使水平在正常范围内,增加亚临床动脉粥样硬化患病率并与远期心血管事件风险增加相关。
关键数值与推荐
- PRECAD试验假设:20-39岁无已知心血管疾病者维持低密度脂蛋白胆固醇<70 mg/dL并严格控制血压和血糖可预防动脉粥样硬化发生和/或进展。
- PRECAD主要终点为总动脉粥样硬化负荷变化,作为心血管疾病的替代指标。
局限性
- 无症状年轻人群(<40岁)的最佳心血管风险因素控制目标未知。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There is growing evidence that the atherosclerotic process that leads to symptomatic cardiovascular disease (CVD) starts at an early age. In young adults, exposure to low-density lipoprotein-cholesterol and other cardiovascular risk factor (CVRF) mediators, even at levels considered within normal limits, increases the prevalence of subclinical atherosclerosis and is associated with greater risk of cardiovascular events later in life. The optimal CVRF targets to prevent CVD in asymptomatic young individuals (<40 years) are unknown. The randomized controlled PRECAD (Prevent Coronary Artery Disease) trial has been developed to assess the potential benefit of an aggressive control of CVRF in otherwise healthy young adults. The hypothesis of PRECAD is that in subjects aged 20 to 39 years without known CVD, maintaining low-density lipoprotein-cholesterol <70 mg/dL and strict control of blood pressure and glucose will prevent the onset of atherosclerosis and/or its progression. The primary endpoint will be the change in total atherosclerosis burden, a surrogate for CVD.
引用
- Devesa A, Ibanez B, Malick WA, et al. Primary Prevention of Subclinical Atherosclerosis in Young Adults: JACC Review Topic of the Week. J Am Coll Cardiol. 2023. PMID: 37993206. doi:10.1016/j.jacc.2023.09.817
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。